Ketamine Gets Controversial FDA Approval for Depression Treatment

March 15, 2019

The FDA has approved a whole new class of antidepressant, and ultrasounds might be far more useful than we thought.

Spotlight

HealthMyne, Inc.

HealthMyne, Inc. (Madison, WI) leverages Point-of-Read quantitative imaging data to drive Point-of-Care clinical decision support workflow modules to enable better patient management decisions, impacting the cost and quality of care by reducing clinical variability.

OTHER VIDEOS

Huawei Cloud AI Model Accelerates New Drug Discovery

video | September 22, 2022

pre-trained AI models have greatly sped up pharma R&D, with multi-year tasks, such as identify lead compounds,...

Watch Now

Smart Home Care System For The Elderly

video | September 26, 2022

Monitor your loved one in their home without a camera. Closer uses no camera to monitor senior’s health status. Wifi sensing based technology enables to scan the room with a safe way....

Watch Now

CARS Microscopy Visualizes Pharmaceutical Tablets During Dissolution

video | September 19, 2022

Coherent anti-Stokes Raman Scattering (CARS) Microscopy Visualizes Pharmaceutical Tablets During Dissolution - a 2 minute Preview of the Experimental Protocol...

Watch Now

Simplify the Procedure and Minimize the Need for Modifications

video | September 23, 2022

Foreclosed properties can be one of the best ways to get a cheap property, but understanding this murky world can be difficult....

Watch Now

Spotlight

HealthMyne, Inc.

HealthMyne, Inc. (Madison, WI) leverages Point-of-Read quantitative imaging data to drive Point-of-Care clinical decision support workflow modules to enable better patient management decisions, impacting the cost and quality of care by reducing clinical variability.

Events